News

Jan 29, 2026 Feb 15 @ 12:08 pm

Disappointing Results from Quince’s Clinical Trial of eDSP in A-T

Quince Therapeutics reports topline results from their Phase 3 “NEAT” trial in A-T.

more
Jan 21, 2026 Feb 15 @ 12:08 pm

Press Release about Intrabio’s A-T Trial Results

IntraBio announces positive trial results of Levacetylleucine for the treatment of ataxia-telangiectasia.

more
Jan 21, 2026 Feb 15 @ 12:08 pm

Encouraging News from an A-T Clinical Trial

IntraBio announced positive results from
its pivotal Phase III clinical trial of a drug for children and adults with A-T.

more
Dec 31, 2025 Feb 15 @ 12:08 pm

Heading into 2026 with big momentum for A-T

The A-TCP is excited about how much possibility this moment holds for A-T research.

more
Dec 22, 2025 Feb 15 @ 12:08 pm

Breaking News about A-T and GRP94

A-TCP funds a researcher who sheds new light on A-T and on how the ATM gene functions in human biology.

more
Dec 1, 2025 Feb 15 @ 12:08 pm

Giving Tuesday 2025

Thank you for helping us surpass the match!

more
Nov 25, 2025 Feb 15 @ 12:08 pm

Replay of A-T Webinars

Find the replays of two webinars co-hosted with the National Ataxia Foundation!

more
Sep 16, 2025 Feb 15 @ 12:08 pm

How Artificial Intelligence Is Helping Speed Up Research and Drug Development for A-T

Artificial Intelligence is starting to change how scientists understand and develop treatments for ataxia-telangiectasia.

more
Jul 30, 2025 Feb 15 @ 12:08 pm

Study of Involuntary Movements to Track A-T Disease Progression

A new study will focus on measuring the involuntary movements people with A-T experience.

more
Apr 29, 2025 Feb 15 @ 12:08 pm

N-Acetyl-L-Leucine Clinical Trial for A-T

IntraBio is conducting a clinical trial to test a product called N-Acetyl-L-Leucine in children and adults with A-T.

more